Stock listing
Frankfurt:NCC0 PharmaTher Holdings Ltd Aktie
German listing (Frankfurt) of PharmaTher Holdings Ltd · home listing CSE:PHRM
Follow PharmaTher Holdings Ltd into a list and get an email when it puts out news.
Home listing price · CSE:PHRM
$0.055 CAD +0.005 (+10.0%)
Close on Oct 28, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:PHRM
- Day range
- $0.055 – $0.055 CADOct 28, 2026
- Volume
- 4,000 sharesOct 28, 2026
- Market cap
- $5.01M CADAt the close on Oct 28, 2026 · price × 91.02M shares outstanding
- 52-week range
- $0.045 – $0.160 CADLowest and highest trades, Oct 29, 2025 – Oct 28, 2026
- Traded on an average day
- $2,600 CADMedian day 15,847 shares · 17 days with no trades · last 3 months, Jul 28, 2026 – Oct 28, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:PHRM · Home | $0.055 CAD | +0.005 (+10.0%) | 4,000 | $0.055 | $0.055 | $0.055 | $0.050 | Close on Oct 28, 2026 |
| OTC:PHRRF | $0.043 USD | +0.006 (+15.6%) | 42,000 | $0.043 | $0.043 | $0.043 | $0.037 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 28, 2026 – Oct 28, 2026 · CSE:PHRM · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.055 | +0.005 | +10.0% | $0.055 | $0.055 | $0.055 | 4,000 | |
| $0.050 | -0.005 | -9.1% | $0.060 | $0.060 | $0.050 | 67,300 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.050 | 82,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 42,061 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 35,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 4,570 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 5,000 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | -0.005 | -7.7% | $0.060 | $0.060 | $0.060 | 5,385 | |
| $0.065 | 0.000 | 0.0% | $0.065 | $0.065 | $0.065 | 0 | |
| $0.065 | +0.010 | +18.2% | $0.060 | $0.065 | $0.060 | 282,061 | |
| $0.055 | +0.005 | +10.0% | $0.055 | $0.060 | $0.055 | 160,000 | |
| $0.050 | -0.005 | -9.1% | $0.055 | $0.055 | $0.050 | 56,183 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | +0.005 | +10.0% | $0.050 | $0.055 | $0.050 | 35,077 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.055 | $0.050 | 27,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 | |
| $0.050 | -0.005 | -9.1% | $0.050 | $0.050 | $0.050 | 42,300 | |
| $0.055 | +0.005 | +10.0% | $0.050 | $0.055 | $0.050 | 197,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 14,916 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 12,888 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 49,084 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 12,077 | |
| $0.050 | 0.000 | 0.0% | $0.055 | $0.055 | $0.050 | 120,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 | |
| $0.050 | -0.005 | -9.1% | $0.050 | $0.050 | $0.050 | 1,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 3,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.060 | $0.050 | 34,225 | |
| $0.055 | 0.000 | 0.0% | $0.060 | $0.060 | $0.055 | 3,077 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 79,227 | |
| $0.060 | 0.000 | 0.0% | $0.055 | $0.060 | $0.055 | 12,077 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | -0.005 | -7.7% | $0.065 | $0.065 | $0.060 | 32,915 | |
| $0.065 | +0.005 | +8.3% | $0.050 | $0.065 | $0.050 | 198,334 | |
| $0.060 | +0.005 | +9.1% | $0.060 | $0.060 | $0.060 | 3,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 49,500 | |
| $0.055 | 0.000 | 0.0% | $0.060 | $0.060 | $0.055 | 19,777 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.060 | $0.055 | 239,727 | |
| $0.055 | -0.005 | -8.3% | $0.065 | $0.065 | $0.055 | 72,507 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 18,337 | |
| $0.060 | +0.010 | +20.0% | $0.050 | $0.060 | $0.050 | 196,932 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 20,000 | |
| $0.050 | -0.005 | -9.1% | $0.050 | $0.050 | $0.050 | 301,004 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 21,000 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 17,170 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 97,411 | |
| $0.055 | 0.000 | 0.0% | $0.055 | $0.055 | $0.055 | 16,777 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.050 | 118,911 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | -0.005 | -7.7% | $0.060 | $0.060 | $0.060 | 10,154 | |
| $0.065 | +0.005 | +8.3% | $0.065 | $0.065 | $0.065 | 50,000 | |
| $0.060 | 0.000 | 0.0% | $0.055 | $0.060 | $0.055 | 4,100 |
- Ticker
- Frankfurt:NCC0
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 25 slides
Latest news
PharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency
Oct 28, 2026
Closed $0.055 (+10.0%) on Oct 28, 2026
PharmaTher Launches M3DICINES(TM) National Network Program to Provide 3D-Printed Medicines for Rare Diseases, Discontinued Medicines, Drug Shortages and National Emergencies
Oct 7, 2026
Closed $0.06 (-7.7%) on Oct 7, 2026
PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES
Oct 5, 2026
Closed $0.065 (+18.2%) on Oct 5, 2026
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform
Oct 1, 2026
Closed $0.05 (-9.1%) on Oct 1, 2026
PharmaTher Selects PD Labs, a National 503A Compounding Pharmacy, as the U.S. Center of Excellence for Its Personalized Medicine and Peptide Platform, PERSONALIZ3D(TM)
Aug 18, 2026
Closed $0.055 (0.0%) on Aug 18, 2026
PharmaTher Establishes PERSONALIZ3D(TM) to Commercialize a Personalized Medicine Platform Combining Telehealth and Pharmaceutical 3D Printing
Aug 11, 2026
Closed $0.05 (-9.1%) on Aug 11, 2026
PharmaTher Collaborates with Craft Health to Evaluate CraftMake(TM) GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides
Jul 29, 2026
Closed $0.065 (+8.3%) on Jul 29, 2026
PharmaTher Launches Personaliz3D Peptides(TM) to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations
Jul 27, 2026
Closed $0.06 (+9.1%) on Jul 27, 2026
PharmaTher Updates Strategy on Personalized Medicines for Peptides and Psychedelics
Jul 15, 2026
Closed $0.05 (0.0%) on Jul 15, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 25 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 27 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 26 slides · October 2026
Investor Presentation (October 2020)
Investor deck · 22 slides · October 2020
PharmaTher Holdings Ltd on 6ix
- News releases
- 23 in the last 12 months · 42 in all · newest Oct 29, 2026 · oldest 2025
- Decks
- 4 decks · latest October 2026
Where PharmaTher Holdings Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:PHRM · Home listing | CSE | Canada | CAD |
| OTC:PHRRF | OTC | United States | USD |
| Cboe Canada:PHRM | Cboe Canada | Canada | CAD |
| Frankfurt:NCC0 · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about PharmaTher Holdings Ltd.